Literature DB >> 21297247

Infectious agents in the pathogenesis of primary biliary cirrhosis.

Oscar-Danilo Ortega-Hernandez1, Nancy-Agmon Levin, Arie Altman, Yehuda Shoenfeld.   

Abstract

Primary biliary cirrhosis (PBC) is a chronic progressive cholestatic liver disease which is characterized by the breakdown of self-tolerance to the highly conserved pyruvate dehydrogenase complex, specially the pyruvate dehydrogenase E2 complex (PDC-E2). The breakdown of the tolerance to such antigens leads to an autoimmune process characterized by portal inflammation and immune-mediated destruction of the intrahepatic bile ducts. Epidemiological studies have suggested that infections agents can trigger or even exacerbate the disease. Among other gram negative bacteria, Escherichia Coli, and Nosphingobium aromaticivorans are the most associated agents reported hitherto. Epidemiological and molecular evidence points towards molecular mimicry between some components of these microorganisms and specific amino-acid sequences that are present in proteins on normal cells of the biliary tract. In this review, we revisit all reports suggesting that infectious agents might be associated with the autoimmune pathogenesis of PBC. We also retrieve the immune molecular mimicry mechanisms that are likely involved with the autoimmune process in PBC.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21297247      PMCID: PMC3835533          DOI: 10.3233/DMA-2010-0771

Source DB:  PubMed          Journal:  Dis Markers        ISSN: 0278-0240            Impact factor:   3.434


  10 in total

1.  Infection of Helicobacter species and liver disease.

Authors:  Kazunari Murakami
Journal:  J Gastroenterol       Date:  2012-04-12       Impact factor: 7.527

Review 2.  Environmental Basis of Autoimmunity.

Authors:  Annarosa Floreani; Patrick S C Leung; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2016-06       Impact factor: 8.667

3.  No rise in incidence but geographical heterogeneity in the occurrence of primary biliary cirrhosis in North East England.

Authors:  Richard J Q McNally; Peter W James; Samantha Ducker; Paul D Norman; Oliver F W James
Journal:  Am J Epidemiol       Date:  2014-01-08       Impact factor: 4.897

Review 4.  Primary biliary cirrhosis is a generalized autoimmune epithelitis.

Authors:  Jun Gao; Liang Qiao; Bingyuan Wang
Journal:  Int J Mol Sci       Date:  2015-03-20       Impact factor: 5.923

5.  Morbid Sequences Suggest Molecular Mimicry between Microbial Peptides and Self-Antigens: A Possibility of Inciting Autoimmunity.

Authors:  Susanta Pahari; Deepyan Chatterjee; Shikha Negi; Jagdeep Kaur; Balvinder Singh; Javed N Agrewala
Journal:  Front Microbiol       Date:  2017-10-09       Impact factor: 5.640

Review 6.  Sympathetic Nerve Hyperactivity in the Spleen: Causal for Nonpathogenic-Driven Chronic Immune-Mediated Inflammatory Diseases (IMIDs)?

Authors:  Denise L Bellinger; Dianne Lorton
Journal:  Int J Mol Sci       Date:  2018-04-13       Impact factor: 5.923

Review 7.  Molecular Pathogenesis of Anti-NMDAR Encephalitis.

Authors:  Hao Ding; Zhihong Jian; Creed M Stary; Wei Yi; Xiaoxing Xiong
Journal:  Biomed Res Int       Date:  2015-06-28       Impact factor: 3.411

Review 8.  Infectome: a platform to trace infectious triggers of autoimmunity.

Authors:  Dimitrios P Bogdanos; Daniel S Smyk; Pietro Invernizzi; Eirini I Rigopoulou; Miri Blank; Shideh Pouria; Yehuda Shoenfeld
Journal:  Autoimmun Rev       Date:  2012-12-22       Impact factor: 9.754

Review 9.  Examining pathogenic concepts of autoimmune hepatitis for cues to future investigations and interventions.

Authors:  Albert J Czaja
Journal:  World J Gastroenterol       Date:  2019-12-07       Impact factor: 5.742

Review 10.  Tracing environmental markers of autoimmunity: introducing the infectome.

Authors:  Dimitrios P Bogdanos; Daniel S Smyk; Pietro Invernizzi; Eirini I Rigopoulou; Miri Blank; Lazaros Sakkas; Shideh Pouria; Yehuda Shoenfeld
Journal:  Immunol Res       Date:  2013-07       Impact factor: 2.829

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.